BPC-157 / TB-500 Blend
The go-to systemic + localized healing combination.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About BPC-157 / TB-500 Blend
This blend combines BPC-157, which drives localized tissue repair and angiogenesis, with TB-500 (thymosin beta-4 fragment), which acts systemically on cell migration and inflammation. Their mechanisms are complementary rather than redundant, making the pair a widely used protocol for injury recovery, soft-tissue healing, and reduced downtime.
Key Benefits
- Localized plus systemic tissue repair
- Promotes angiogenesis and cell migration
- Reduces inflammation during recovery
- Convenient single-vial protocol
Set a goal (top of the page) to see how BPC-157 / TB-500 Blend scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Injection site reactions
- Mild fatigue
- Head rush
- Temporary lightheadedness
Legal & Regulatory Status
Research use only. Not FDA-approved. No studies exist on this specific combination; both components (BPC-157, TB-500) have only preclinical (animal) evidence for these uses.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
No citations available. We could not locate indexed peer-reviewed literature for this compound specifically. That absence is the reason for its evidence rating — treat any claims about it, including ours, with corresponding caution.
